BioCentury
ARTICLE | Financial News

Illumina, Actelion boost guidance

October 22, 2014 3:53 AM UTC

Illumina Inc. (NASDAQ:ILMN) gained $2.1 billion in market cap on Tuesday in the wake of its earnings release after market on Monday. The shares added $15.08 to $179.55 after the sequencing company said revenue jumped 35% year over year to $480.6 million and raised its revenue guidance for the year. The company now anticipates revenue to grow about 30% over 2013, up from prior guidance of 25-26% growth.

Non-GAAP diluted EPS is now expected to be $2.63-$2.65, up from prior guidance of $2.26-$2.28. Adjusted gross margins climbed to 73.2% from 70.9% in 2Q14. ...